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Abstract
Identification of regulatory elements within the genome is crucial for understanding the mechanisms that govern cell type–
specific gene expression. We generated genome-wide maps of open chromatin sites in 3T3-L1 adipocytes (on day 0 and day
8 of differentiation) and NIH-3T3 fibroblasts using formaldehyde-assisted isolation of regulatory elements coupled with
high-throughput sequencing (FAIRE-seq). FAIRE peaks at the promoter were associated with active transcription and
histone modifications of H3K4me3 and H3K27ac. Non-promoter FAIRE peaks were characterized by H3K4me1+/me3-, the
signature of enhancers, and were largely located in distal regions. The non-promoter FAIRE peaks showed dynamic change
during differentiation, while the promoter FAIRE peaks were relatively constant. Functionally, the adipocyte- and
preadipocyte-specific non-promoter FAIRE peaks were, respectively, associated with genes up-regulated and down-
regulated by differentiation. Genes highly up-regulated during differentiation were associated with multiple clustered
adipocyte-specific FAIRE peaks. Among the adipocyte-specific FAIRE peaks, 45.3% and 11.7% overlapped binding sites for,
respectively, PPARc and C/EBPa, the master regulators of adipocyte differentiation. Computational motif analyses of the
adipocyte-specific FAIRE peaks revealed enrichment of a binding motif for nuclear family I (NFI) transcription factors. Indeed,
ChIP assay showed that NFI occupy the adipocyte-specific FAIRE peaks and/or the PPARc binding sites near PPARc, C/EBPa,
and aP2 genes. Overexpression of NFIA in 3T3-L1 cells resulted in robust induction of these genes and lipid droplet
formation without differentiation stimulus. Overexpression of dominant-negative NFIA or siRNA–mediated knockdown of
NFIA or NFIB significantly suppressed both induction of genes and lipid accumulation during differentiation, suggesting a
physiological function of these factors in the adipogenic program. Together, our study demonstrates the utility of FAIRE-seq
in providing a global view of cell type–specific regulatory elements in the genome and in identifying transcriptional
regulators of adipocyte differentiation.
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Introduction
Sequencing allowed identification and mapping of the human
genome [1]. Transcriptional regulation of genes is essential for
manifesting cellular phenotypes and complex biological processes.
Coordinated actions of transcription factors and cofactors on
regulatory DNA sequences produce transcriptional activation of
the eukaryotic gene. Therefore, identification and mapping of the
genome’s regulatory elements is critical for understanding how
cell-type-selective regulation of genes in the genome is achieved.
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.Traditionally, regulatory elements have been identified by
DNase I hypersensitivity assay combined with Southern blot
analysis [2]. That assay coupled with microarray or high-
throughput sequencing (DNase-Chip or DNase-seq) were effec-
tively applied in genome-wide identification of open chromatin
regions [3,4,5,6]. Lieb and his colleagues recently developed
formaldehyde-assisted isolation of regulatory elements (FAIRE) as
a simple procedure to isolate nucleosome-depleted DNA from
chromatin [7,8]. FAIRE detects open chromatin structure much
the way the DNase I hypersensitivity assay does [8,9]—but with
advantages, like obviating the need for clean nuclei preparation
and laborious enzyme titrations [7,8]. Coupled with high-
throughput sequencing (FAIRE-seq), FAIRE allows unbiased
identification of potential regulatory elements without requiring
prior knowledge of (or about) binding factors. FAIRE-seq’s
genome-wide detection of open chromatin genomic regions in
human pancreatic islets was successfully used to determine a causal
single nucleotide polymorphism in loci associated with type 2
diabetes development in genome-wide association studies [10].
The adipocyte is central in controlling energy balance and
whole-body glucose and lipid homeostasis [11]. Advances in
adipocyte research have shown that adipose tissue stores excess
energy and secretes hormones and metabolites to communicate
with other organs, maintaining systemic metabolic homeostasis
[12]. Peroxisome proliferator-activated receptor gamma (PPARc;
NR1C3) is both necessary [13,14,15] and sufficient [16] for
adipocyte differentiation. Necessary for both development and
maintenance of mature adipocytes, PPARc is crucial in systemic
glucose and lipid homeostasis [13,14,15,17], and, importantly, is
the molecular target of thiazolidinediones, widely prescribed for
obese diabetics [18]. C/EBPa-b-d act with PPARc, forming the
adipogenic transcription cascade [19]. C/EBPb and d are induced
by adipogenic stimulus, inducing PPARc, which activates
expression of C/EBPa, which binds and further activates
expression of PPARc, providing a positive regulatory loop
[11,20]. Genome-wide approaches now dissect the transcriptional
mechanisms of adipocyte differentiation. ChIP-chip or ChIP-seq
studies of adipogenic regulators [21,22,23,24,25,26,27,28,29] have
provided valuable mechanistic insights into adipogenic transcrip-
tion never before gained by conventional experiments: New
concepts include co-localization of PPARc and cell type–specific
transcription factors [27], low conservation rate of PPARc binding
sites between murine and human adipocytes [28] and the role of
C/EBPb as a pioneer factor that establishes ‘‘hot spots’’ where
multiple adipogenic regulators cooperatively work in the very early
stage of differentiation [6].
Our study took an unbiased approach to mapping adipocyte-
specific regulatory elements in the genome by using FAIRE in
3T3-L1 adipocytes (on day 0 and day 8 of differentiation) and
NIH-3T3 fibroblasts. We show that the FAIRE peaks contain
regulatory elements such as promoters, enhancers and insulators,
and that adipocyte-specific non-promoter FAIRE peaks are
functionally linked to genes regulated during differentiation—
about half these peaks being overlapped by PPARc. We show that
highly regulated genes in adipocyte differentiation are associated
with clusters of multiple adipocyte-specific non-promoter FAIRE
peaks. Furthermore, because FAIRE does not require a prioi
knowledge of bound transcription factors, we could employ
computational motif analyses of DNA sequences from the
adipocyte-specific FAIRE peaks in an unbiased manner and
identify a motif for nuclear family I (NFI) transcription factors in
addition to motifs for PPAR and C/EBPs. We show the functional
role of NFIA and NFIB in adipocyte differentiation. We
demonstrate the utility of FAIRE-seq both in providing a global
view of cell type–specific cis-regulatory elements in the genome
and identifying transcriptional regulators of adipocyte differenti-
ation.
Results
Genome-Wide Profiling of Open Chromatin Regions in
3T3-L1 Adipocytes by FAIRE-seq
Regulatory elements in the genome are characterized by open
chromatin structures accessible to regulatory factors [30]. To
explore genome-wide changes in open chromatin conformation
during adipocyte differentiation, we used FAIRE—a method of
isolating genomic regions depleted of nucleosomes [7]—combined
with high-throughput sequencing (FAIRE-seq) to identify open
chromatin sites in the adipogenic cell line 3T3-L1 before (day 0)
and after (day 8) differentiation and in NIH-3T3 fibroblasts, which
cannot differentiate into adipocytes. This approach identified in
the genome 37,781 FAIRE peaks in 3T3-L1 on day 0 and 26,611
on day 8, plus 36,111 in NIH-3T3 cells—all, with a false discovery
rate of ,10
24. By using ChIP-seq analyses, we also generated
genome-wide maps of binding sites for PPARc, the master
regulator of adipocyte differentiation, for RXRa, its heterodimer
partner, for histone H3 lysine 4 trimethylation (H3K4me3), and
for CCCTC-binding factor (CTCF) [31].
Figure 1 shows a representative map of results generated
near Klf15 and Pparg, both transcription factors up-regulated by
differentiation, and both important in adipocyte differentiation
[16,32]. Consistent with previous observations [10], 28% of the
FAIRE peaks were detected near the transcription start sites (TSSs
6500 bp) of RefSeq genes [33] and are referred to as promoter
FAIRE peaks (Figure S1A), while 72% were located outside known
TSSs, and are referred to as non-promoter FAIRE peaks. Notably,
only 8% of the non-promoter FAIRE peaks were located in a
25 kbproximalpromoterregionwhilethemajorityofnon-promoter
FAIRE peaks were located in introns and distal regions (Figure
S1A). Average profiling revealed that a FAIRE signal, H3K4me3
Author Summary
Humans consist of a few hundred types of specialized-
function cells. Spatial and temporal transcriptional regula-
tion of genes is essential for manifestation of cellular
phenotypes. Identification of regulatory regions in the
genome is central to understanding the mechanism of cell
type–specific gene regulation. Recently developed high-
throughput sequencing technology and computational
analyses allow genome-wide investigation of the genome’s
chromatin structure. Using the FAIRE-seq technique, we
identified the genome’s open chromatin regions, which
harbor regulatory elements in adipocytes. Open chromatin
regions distal to genes’ transcription start sites significantly
differ among cell types. Multiple cell type–specific open
chromatin regions exist near genes regulated during
adipocyte differentiation. Computational motif analysis of
adipocyte-specific open chromatin regions revealed enrich-
ment of a binding motif for the NFI transcription factor
family. These factors bind to the regulatory elements near
adipogenic PPARc, C/EBPa, and aP2 genes and regulate
their expression. Overexpression of NFIA in 3T3-L1 cells
resulted inrobust inductionof thesegenesandlipiddroplet
formation without differentiation stimulus and knockdown
of NFIA or NFIB significantly suppressed both induction of
genes and lipid accumulation during differentiation. Our
study demonstrates the utility of FAIRE-seq in providing a
global view of regulatory elements and in identifying
transcriptional regulators of cellular functions.
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TSSs of actively transcribed genes (Figure S1B and S1D). On the
other hand, non-promoter FAIRE peaks were accompanied by
monomodal enrichment of H3K4me1 and were devoid of
H3K4me3 enrichment, a condition described as the signature of
enhancers [34,35] (Figure S1D). CTCF binding sites are important
in insulator function and high-order chromatin structure [31]. The
CTCF binding sites in our study (day 0 or day 8) were largely
overlapped by those in a study by Mikkelsen (day 0 or day 7) [28]
(86.3% and 88.5%, respectively). CTCF binding accounted for
aboutonefifthofeitherthepromoterornon-promoterFAIREpeaks
(Figure 1 and Figure S1C). Collectively, these data suggest that the
openchromatinsites identified by FAIRE-seqshow characteristicsof
regulatory elements such as promoter, enhancer and insulator.
Analysis of Differentiation-Dependent Non-Promoter
FAIRE Peaks
We next compared the FAIRE peaks in 3T3-L1 cells on day 0
and day 8 and in NIH-3T3 cells. The promoter FAIRE peaks
were relatively constant among the three groups. Over 70% of
Figure 1. Genome-wide profiling of open chromatin regions by FAIRE-seq in 3T3-L1 adipocyte differentiation. Openchromatinregions
detected by FAIRE-seq were observed in both promoter and non-promoter regions. The non-promoter FAIRE peaks were associated with the binding of
PPARc/RXRa or CTCF, and with the enhancer signature H3K4me1(+)/me3(2) and H3K27ac modification—while the promoter FAIRE peaks were
associated with H3K4me3 and H3K27ac modification. Bars below the FAIRE peaks data represent statistically significant FAIRE positive peaks (FDR,10
24).
Red asterisks indicate the adipocyte-specific FAIRE peaks on day 8 (see Figure 2B for definition). Multiple adipocyte-specific FAIRE peaks were located
within genomic regions near Klf15 (A) and Pparg (B) in 3T3-L1 adipocytes. Data marked ({) were obtained from Mikkelsen et al. [28] (GSE20752).
doi:10.1371/journal.pgen.1002311.g001
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were shared by all three groups (Figure 2A). In contrast, non-
promoter FAIRE peaks showed dynamic change. The three
groups shared only 25%, 45%, and 26% of non-promoter FAIRE
peaks in, respectively, day 0 and day 8 3T3-L1 cells and NIH-3T3
cells. This contrasts with an invariable biding pattern of CTCF in
Figure 2. Cell type– and differentiation-dependent FAIRE peaks. (A) Venn diagrams comparing the FAIRE peaks among 3T3-L1 (day 0), 3T3-
L1 (day 8) and NIH-3T3 at promoter (+/2500 bp from RefSeq TSS) and non-promoter regions. The promoter FAIRE peaks were relatively constant
among the three cell groups while the non-promoter FAIRE peaks were highly variable. (B) The FAIRE peaks in 3T3-L1 (day 0 or day 8) were divided
into tertiles by peak height and adipocyte- (red boxes) and preadipocyte-specific (green boxes) FAIRE peaks, and were defined as indicated. (C) A heat
map showing enrichment of the adipocyte- and preadipocyte-specific FAIRE peaks in the vicinity (+/225 kb from TSS) of genes up-regulated or
down-regulated during differentiation. The horizontal bars in the two right panels indicate each gene with Ad or pAd FAIRE peaks in the vicinity (+/
225 kb from TSS). (D) Fractions of genes that were up-regulated (left) or down-regulated (right) more than two-fold during differentiation among
genes that had the indicated number of adipocyte- (red), preadipocyte-specific (green) or invariant (blue) FAIRE peaks. (E) The number of the
adipocyte- (red), preadipocyte-specific (green) or invariant (blue) FAIRE peaks associated with genes that were stratified by the ratio of the expression
levels between preadipocytes and adipocytes. Each FAIRE peak was defined as associated with the nearest gene in analyses (D) and (E). (F) Ontology
analysis by DAVID of genes associated (+/225 kb from TSS) with adipocyte-specific FAIRE peaks [13]. (G) Venn diagrams showing the numbers and
overlap of the binding sites for PPARc and RXRa in 3T3-L1, day 0 and day 8. (H, I) Fractions of the non-promoter FAIRE peaks that overlap PPARc
binding sites (day 8) (H) or C/EBPa binding sites (Schmidt et al., GSE27450 [86]) (I). PPARc and C/EBPa represented 45.3% and 11.7% of the adipocyte-
specific FAIRE peaks (average of red bars).
doi:10.1371/journal.pgen.1002311.g002
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promoter CTCF binding sites on day 0 overlapped those on day 8.
What’s more, a significant proportion of the non-promoter FAIRE
peaks were cell type–specific (Figure 2A), implying the role of non-
promoter regulatory elements in cell type–specific transcriptional
regulation. We divided the non-promoter FAIRE peaks in day 0
and day 8 3T3-L1 cells into tertiles by FAIRE signal intensity, and
defined adipocyte- or preadipocyte-specific FAIRE peaks as
indicated by red or green boxes in the 4-by-4 table in Figure 2B.
By this definition, we judged each non-promoter FAIRE peak as
adipocyte-specific, preadipocyte-specific or invariant (Figure 2B).
Figure 1, Figures S2 and S3 show examples of adipocyte-specific
non-promoter FAIRE peaks (indicated by asterisks) in loci near
Klf15, Pparg, Cebpa [16,20], Mgll [36], Srebf1 and cidec [37]—all of
which are abundantly expressed in adipose tissue and induced
during adipocyte differentiation (data not shown). Remarkably,
multiple adipocyte-specific FAIRE peaks existed in the vicinity of
these genes and included introns and downstream regions
(Figure 1, Figures S2 and S3).
To determine whether non-promoter FAIRE peaks were
functionally associated with cell type–specific gene expression,
we analyzed the relationship between the presence of the
adipocyte- or preadipocyte-specific non-promoter FAIRE peaks
and the change in gene expression during adipocyte differentia-
tion. Those FAIRE peaks were enriched in the vicinity of genes,
expression levels of which were highly induced or suppressed
during adipocyte differentiation (Figure 2C). Importantly, as the
number of the adipocyte-specific FAIRE peaks associated with a
gene increased, the fraction of up- or down-regulated genes
increased or decreased, respectively (Figure 2D, red lines), while as
the number of associated preadipocyte-specific FAIRE peaks
increased, the fraction of up- or down-regulated genes decreased
or increased, respectively (Figure 2D, green lines). Conversely, the
more robust the induction of the expression level of a gene during
adipocyte differentiation, the greater the numbers of adipocyte-
specific FAIRE peaks associated with the gene (Figure 2E, red
line). In contrast, the more robust the reduction of the expression
levels of a gene during adipocyte differentiation, the greater the
numbers of associated preadipocyte-specific FAIRE peaks that
were associated (Figure 2E, green line). Invariant FAIRE peaks
were associated specifically with neither up- nor down-regulated
genes (Figure 2E, blue line). We next employed a gene ontology
(GO) analysis tool (DAVID) [38] to determine what kind of
biological processes were associated with genes bound by the
adipocyte-specific FAIRE peaks. We found that biological
processes (e.g., adipocyte differentiation) were significantly en-
riched compared with the genomic background (Figure 2F). It was
of interest that embryonic placenta development—for which
PPARc is critical [13,14,15]—was enriched (Figure 2F). Together,
these data highlight the role of the cell type–specific non-promoter
open chromatin sites detected by FAIRE-seq in differentiation-
dependent transcriptional regulation.
Analysis of Binding Sites for PPARc and RXRa in 3T3-L1
Adipocytes
PPARc is key regulator of adipocyte development [16,20]. To
elucidate the contribution of PPARc to adipocyte-specific
transcriptional regulation, we conducted ChIP-seq analyses using
antibodies specific for either PPARc or RXRa [24] in 3T3-L1
adipocytes at 36 hours and day 8 after induction of differentiation.
The number of PPARc binding sites increased during differenti-
ation while that of RXRa binding sites remained virtually constant
(Figure 2G). Significant overlap between the PPARc and RXRa
binding sites was consistent with the heterodimer formation of
PPARc and RXRa [21,39] (Figure 2G). Microarray and GO
analysis revealed that the PPARc binding sites were enriched in
the vicinity of genes up-regulated by adipocyte differentiation
(Figure S4B) and the bound genes were associated with adipocyte
differentiation and lipid metabolism (Figure S4C). Using MEME
[40], we performed de novo motif analysis of genomic regions
bound by PPARc, and found that the AGGTCA-n-AGGTCA
(called DR-1) shown was the most over-represented one (E-value
1.3610
2055) (Figure S4A). An extension AGT 59 outside of DR-1
appeared to correspond to the direct interaction between the DNA
and the hinge region between the DNA-binding domain and the
ligand-binding domain [41].
As shown in genomic loci (Figure 1, Figures S2 and S3), a
significant proportion of adipocyte-specific non-promoter FAIRE
peaks overlapped the PPARc/RXRa binding sites. To determine
the contribution of PPARc to the adipocyte-specific open
chromatin regions, we calculated percent fractions of the FAIRE
peaks that were stratified by FAIRE signal in 3T3-L1 on day 0 and
day 8 (Figure 2B) —and that overlapped either the PPARc
binding sites (Figure 2G) or C/EBPa binding sites in 3T3-L1
reported by Schmidt et al. [42]. Both PPARc and C/EBPa
binding sites were enriched in the fractions of adipocyte-specific
FAIRE peaks (Figure 2H and 2I), and they respectively accounted
for 45.3% and 11.7% of the adipocyte-specific FAIRE peaks
(averages of the red bars in Figure 2H and 2I). These data support
the role of PPARc and C/EBPa as primary transcription factors
that drive adipocyte-specific gene expression—although they may
not explain all of it.
Clustering of Multiple Adipocyte-Specific Non-Promoter
FAIRE Peaks and the PPARc Binding Sites
Genes that were highly induced by adipocyte differentiation
often harbored multiple adipocyte-specific FAIRE peaks and/or
PPARc binding sites in their vicinity, as suggested by the linear
correlation between the number of the associated adipocyte-
specific FAIRE peaks and the robustness of the induction of the
gene by adipocyte differentiation (Figure 2D and 2E). (See
Figure 1, Figures S2 and S3 for representative genes.) To
determine whether these multiple regions have functional
regulatory elements, we selected AdipoR2 [43,44]. Although
AdipoR2 was regulated by PPARc and PPARa ([45] and data not
shown), conventional 22 kb promoter studies failed to identify the
response element [46]. Our ChIP-seq analysis revealed a cluster of
multiple PPARc/RXRa binding sites in the intron 1, downstream
of the TSS of AdipoR2 (Figure S2B, arrow heads). We identified
putative DR-1 motifs in these biding sites (Figure 3A) and tested
them by gel-shift assay and luciferase assay. These motifs were
indeed bound by the PPARc/RXRa heterodimer, and were
functional in the luciferase assay (Figure 3B and 3C), suggesting
the functionality of these elements and the advantage of a genome-
wide approach over the conventional ‘‘promoter-bashing’’ ap-
proach to identifying such response elements.
Recent genome-wide studies revealed clustering of open
chromatin regions detected by Dnase I hypersensitivity assay or
by FAIRE in the genomes of CD4+ T cells [47], pancreatic islet
cells [10,48] and binding sites for certain transcription factors
[49])—certainly the PPARc binding sites and adipocyte-specific
FAIRE peaks in our analyses tended to form clusters as indicated
by an additional peak in distribution histograms of the distance to
the nearest peak among the PPARc binding sites or the adipocyte-
specific FAIRE peaks (Figure 4A). We calculated the total number
of PPARc binding site clusters for different window sizes and
compared them with a random data set comprised of the same
number of sites (Figure 4B). The PPARc binding sites had a
Mapping of Open Chromatin in Adipocytes by FAIRE
PLoS Genetics | www.plosgenetics.org 5 October 2011 | Volume 7 | Issue 10 | e1002311Figure 3. Identification of functional regulatory elements in the intron 1 of Adipor2. The PPARc binding sites in the Adipor2 gene locus
(Figure S2B, arrow heads) were analyzed. (A) Putative DR-1 motifs (PPAR response elements or PPREs) in the regions. ARE6 and ARE7 in the 25.4 kb
promoter upstream of Fabp4(aP2) were previously identified PPREs [87]. (B) Gel shift assay showing binding of the PPARc/RXR heterodimer to the
motifs. An arrow indicates the PPARc/RXRa heterodimer bound by radiolabeled probe. Competition by cold oligos showed the specificity of the
binding. (C) Luciferase reporter assay in HEK293T cells. Most of the motifs inserted into reporter vectors with the tk minimal promoter responded to
over-expressed PPARc/RXRa and stimulation with its synthetic ligand, rosiglitazone. The 25.4 kb promoter of PPARc target gene Fabp4 (aP2) [84] was
included as a positive control.
doi:10.1371/journal.pgen.1002311.g003
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from 800 bp to ,30 kb. Similar results were obtained for the
adipocyte-specific FAIRE peaks (Figure 4A and 4B).
On the other hand, multiple genes involved in adipocyte
function [55,56,57] were often co-regulated in certain genomic
regions that harbor clusters of adipocyte-specific regulatory
elements (see Figure S2C, Figure 4C, and Figure S5). We
therefore statistically tested—method in reference [50]—to see if
neighboring genes tended to be co-regulated during adipocyte
differentiation, and found that neighbors of highly induced genes
(.10 fold) were indeed more likely to be up-regulated over three
fold (18%, or 112 of 618 neighbors) than the 2,012 of 21,343 total
genes (9%) that were up-regulated over three fold (P=1.26610
212,
one-sided Fisher test). Neighbors of randomly selected genes were
not significantly up-regulated (p=20.67, average of 1,000 trials,
Figure 4D). Together, these data suggest that the transcriptional
regulation of genes during adipocyte differentiation involves
multiple adipocyte-specific regulatory elements—which tend to
form clusters—and that co-regulation of neighboring genes often
occurs during adipocyte differentiation.
Sequence Motif Analyses of DNA Sequences of the
Adipocyte-Specific Non-Promoter FAIRE Peaks
Next, we performed enrichment analyses of known motifs using
AME in the MEME suite and the TRANSFAC [51] and JASPER
[52] motif databases to identify motifs enriched in either
adipocyte- or preadipocyte-specific FAIRE peaks compared with
the background (statistical values shown as corrected p-value in
Figure 5). We also determined the enrichment ratio (Ad/pAd) by
calculating the ratio of occurrence of a motif in the adipocyte-
specific FAIRE peaks and in the preadipocyte-specific FAIRE
peaks as described in reference [28]. Using both parameters, we
obtained motifs that had been significantly enriched in either kind
of FAIRE peak and that occurred in significantly different
number. Figure 5 shows the top of the list of TRANSFAC motifs
enriched in the adipocyte- and preadipocyte-specific FAIRE
Figure 4. Statistical analyses for clustering of adipocyte-specific FAIRE peaks and PPARc binding sites and co-regulation of
neighbor genes during adipogenesis. (A) Histogram showing distribution of intervals (defined as distances to the nearest neighbor sites) among
all PPARc peaks (left) and among the adipocyte-specific FAIRE peaks (right). Note that there was increased occurrence of sites separated by short
intervals (indicated by asterisks). See [48] for details of the method. (B) Clustering analysis of the PPARc binding sites and the adipocyte-specific FAIRE
peaks by counting the total number of clusters (defined as more than two peaks) determined for windows with indicated width. The PPARc binding
site or adipocyte-specific FAIRE peak clusters occurred more frequently in the observed data set than in random data with the same number of sites.
The difference in the number of clusters was observed at window sizes ranging from 800 bp to 30,100 kb compared with the random sample. See
reference [47] for details of the method. (C) Microarray analysis showing both Slc2a4 (Glut4) and Ybx2 included in the adipocyte-specific FAIRE peak
cluster (Figure S2C) co-regulated during differentiation. (D) Neighbors of highly induced genes (.10 fold) were more likely to be up-regulated over
three fold (18%, or 112 of 618 neighbors) than the 2,012 of 21,343 total genes (9%) that were up-regulated over three fold (p=1.26610
212, one-sided
Fisher test). Neighbors of randomly selected genes were not significantly up-regulated (p=20.67, average of 1,000 trials). See reference [50] for
method.
doi:10.1371/journal.pgen.1002311.g004
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were among the list, consistent with their critical roles in
adipogenic transcription. Motif analyses using the JASPER motif
database showed enrichment of the motifs for PPARc, C/EBPs
and the motif for Zfp423, a recently identified adipogenic
regulator [53] (Figure S6). Motif analyses of the preadipocyte-
specific FAIRE peaks showed significant enrichment of a motif for
AP-1, a downstream transcription factor complex of the growth
factor/MAP kinase signaling pathways, which include epidermal
growth factor and c-Jun N-terminal kinases, known inhibitors of
adipogenesis [54,55] (Figure 5 and Figure S6). We also performed
de novo motif analysis (MEME) [40] of the adipocyte-specific
FAIRE peaks, and observed significant enrichment of motifs that
corresponded to those for PPARc and C/EBPs (Figure S7).
Together, these instances of enrichment of known regulators
indicate the validity of this approach.
Identification of NFI Family Transcription Factors as Novel
Regulators of Adipocyte Differentiation
There were several other motifs for transcription factors, their
functions not previously linked to adipocyte differentiation
(Figure 5, Figures S6 and S7). We focused on a motif for the
NFI family transcription factors. The murine NFI family consists
of NFIA, NFIB, NFIC and NFIX, and was identified as a site-
specific DNA-binding protein that bound to the adenovirus origin
of replication [56]. It forms a dimer to bind to the symmetric
consensus sequence TTGGC(N5)GCCAA [57]. We first exam-
ined the expression change of these factors in in vitro adipocyte
differentiation and found that the expression of NFIA and NFIB
were significantly induced during differentiation of 3T3-L1 and of
another adipogenic cell line, 3T3-F442A (Figure 6A and 6C).
Consistent with this pattern, both NFIA and NFIB were highly
expressed in a variety of adipose tissue depots in addition to the
brain (Figure 6B). We next examined the effect of siRNA
knockdown of NFIA and NFIB on adipogenic gene regulation
and adipocyte differentiation (Figure 6C). Interestingly, induction
of the expression of the adipogenic transcription factors PPARc
and C/EBPa and of downstream genes was significantly
suppressed by siRNA knockdown of either NFIA or NFIB
(Figure 6C). Consistent with the gene expression change, we
observed significant reduction of lipid accumulation as judged by
oil red O staining, suggesting physiological roles for NFIA and
Figure 5. Known motif enrichment analysis of adipocyte- or preadipocyte-specific FAIRE peaks (TRANSFAC motifs). Enrichment
analysis of the adipocyte- (left) and the preadipocyte-specific (right) FAIRE peaks for known motifs in the TRANSFAC database (Release 2010.4)
performed by using AME in the MEME suite. After removing repeat regions with RepeatMasker [83], DNA sequences from the center 150 bp regions
of the top 2,000 cell type–specific FAIRE peaks were analyzed (p-value report threshold : 0.05). Motif enrichment ratios (Ad/pAd FAIRE) for motifs in
the TRANSFAC database were also determined by a method described in reference [28]. Motifs with an enrichment ratio greater than 1.20 (for the
adipocyte-specific FAIRE peaks, left) or less than 0.833 (for the preadipocyte-specific FAIRE peaks, right) are shown in the table. See ‘‘Materials and
Methods’’ for details.
doi:10.1371/journal.pgen.1002311.g005
Mapping of Open Chromatin in Adipocytes by FAIRE
PLoS Genetics | www.plosgenetics.org 8 October 2011 | Volume 7 | Issue 10 | e1002311NFIB in adipocyte differentiation (Figure 6D). We confirmed the
effect of NFIA and NFIB knockdown on adipogenesis by using
independent pooled siRNA (Figure S8).
We next asked whether overexpression of these factors influence
adipocyte differentiation. We amplified NFIA and NFIB coding
sequences from cDNA prepared from adipocytes, and cloned them
into retroviral pMXs-puro vectors. We also made a dominant
negative NFIA that lacks the C-terminal transactivation/repres-
sion domain (NFIA-DN) [58]. Overexpression of NFIA—but not
NFIA-DN or NFIB—resulted in robust induction of PPARc,C /
EBPa and aP2 (Figure 7A) at a basal state. Surprisingly, the
induction of these factors was robust enough to make the cells to
form lipid droplets visible and stainable by oil red O even before
initiation of differentiation by the DMI (dexamethasone, IBMX
and insulin) treatment (Figure 7B and 7C). However, after the DMI
treatment, NFIA-expressing cells were overtaken by control cells,
and on day 7, NFIA and NFIB overexpressing cells showed
attenuated differentiation (Figure 7D and 7E). We speculate that
this was caused by secondary effects of overly strong overexpression
levels (.30 fold, Figure 7A). Almost complete suppression of
adipogenesis by NFIA-DN overexpression was consistent with the
results of knockdown experiments (Figure 6, Figure 7D and 7E).
Nevertheless, the robust induction of PPARc, C/EBPa and aP2 by
NFIAoverexpressionat the basalstate impliesdirectactionofNFIA
on transcriptional control of these factors.
To dissect the mechanism by which NFIs regulate PPARc,C /
EBPa and aP2, we examined DNA sequences of the adipocyte-
specific FAIRE peaks and/or the PPARc binding sites in the
vicinity of these factors and found that some of them have NFI
binding motifs as listed in Figure 8A. ChIP analysis using an anti-
NFI antibody confirmed actual binding of NFI to these sites
(Figure 8B and 8C). We extended this experiment by counting NFI
motifs in the FAIRE peaks on a genome-wide scale. Interestingly,
percent fractions of genes harboring NFI binding motifs in the
FAIRE peaks were higher when the genes were bound by PPARc
and induced during differentiation (Figure 8D), indicating a
significant degree of specificity for the NFI’s action on the
adipogenic transcriptional program.
Figure 6. NFIA and NFIB are novel regulators of adipocyte differentiation. (A) Transcriptional regulation of NFI transcription factors during
adipocyte differentiation (3T3-F442A). (B) Tissue distribution of the NFI family genes. Expression levels relative to 36B4 in various tissues were
determined by qPCR. (C, D) Effects of siRNA-mediated knockdown of NFIA and NFIB on adipogenic gene expression (C) and lipid accumulation in 3T3-
L1 adipocytes judged by oil red O staining (D). Knockdown of either NFIA or NFIB resulted in suppression of the induction of PPARc, C/EBPa and the
PPARc target gene, aP2, as well as increase in lipid accumulation during adipocyte differentiation.
doi:10.1371/journal.pgen.1002311.g006
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seq and computational motif analyses is useful in identifying novel
regulators of adipocyte differentiation.
Comparison of FAIRE Peaks between Undifferentiated
3T3-L1 and NIH-3T3 Cells
The 3T3-L1 adipogenic cell line was established by isolating
clonal sublines of mouse fibroblast line 3T3 [59]. Lastly, we
compared FAIRE peaks between ‘undifferentiated’ 3T3-L1 and
NIH-3T3 cells. As shown in Figure 2A, a substantial proportion of
FAIRE peaks was unique to either 3T3-L1 or NIH-3T3 cells. We
defined non-promoter FAIRE peaks as specific to 3T3-L1and
NIH-3T3—as we did for the adipocyte- or preadipocyte-specific
FAIRE peaks in Figure 2B. The 3T3-L1- or NIH-3T3-specific
FAIRE peaks were enriched in the vicinity of genes whose
expression levels were higher in 3T3-L1 or NIH-3T3, respectively
(Figure S9A). Motif analysis of the 3T3-L1-specific FAIRE peaks
showed that the binding motif for EBF (Figure S9B) had the
highest enrichment ratio (1.81) and a statistically significant p-
value of 3.9E-3. Although the p-value of the motif for PPARc/
RXR did not reach statistical significance, that motif had an
enrichment ratio of 1.84. These two factors were among the
handful that were proven to transform NIH-3T3 cells into
adipocytes when ectopically introduced [16,60].
Discussion
We demonstrated that genome-wide mapping of open chroma-
tin regions by FAIRE-seq is a simple, accurate method that allows
a snapshot view of regulatory elements in the genome. Although
open chromatin regions detected by FAIRE-seq include promoters
of transcribed genes, enhancers and insulators, open chromatin
regions that vary in two different conditions likely contain
regulatory elements that play roles in the specific biological
process. By comparing open chromatin regions in preadipocytes
and adipocytes, we identified the adipocyte- and preadipocyte-
specific FAIRE peaks in the genome. Functionally, we demon-
strated that the adipocyte-specific FAIRE peaks were associated
with genes up- regulated by adipogenesis while the preadipocyte-
specific FAIRE peaks were associated with genes down-regulated
by adipogenesis (Figure 2C, 2D and 2E). Adipocyte gene
Figure 7. Overexpression of NFIA, NFIB, and dominant negative NFIA in 3T3-L1 cells. (A) Expression analysis of overexpressed NFI factors
(upper panel) and adipogenic PPARc, C/EBPa and aP2 (lower panel). Note, overexperssion of NFIA resulted in a robust induction of adipogenic
factors. (B) Microscopic pictures of 3T3-L1 cells overexpressing NFI factors at confluence stained by oil red O (day 0). (C) Close examination of NFIA-
overexpressing cells revealed formation of lipid droplets without adipogenic stimulus before differentiation. (D) Time course of expression levels of
PPARc, C/EBPa and aP2 during differentiation. Note, the induction of these genes by NFIA overexpression was overtaken by that of control cells, and
on day 7, NFIA and NFIB overexpressing cells showed attenuated differentiation. Dominant negative NFIA showed almost complete suppression. (E)
Oil red O staining of 3T3-L1 overexpressing NFI factors on day 7.
doi:10.1371/journal.pgen.1002311.g007
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distal to transcription start sites (TSSs): greater induction of gene
expression by differentiation means greater likelihood that more
adipocyte-specific FAIRE peaks are associated with the gene
(Figure 2D and 2E). This implies that optimal gene transcriptional
regulation may require coordinated actions of multiple regulatory
elements. Therefore, although valuable and informative, the
proximal promoter assay may not always be sufficient (e.g.,
AdipoR2, see Figure S2B and Figure 3). Nevertheless, the
importance of proximal promoter regions is obvious given the
fact that many proximal promoter regions are successfully used to
generate tissue-specific transgenic lines. Recently, Mikkelsen et al.
demonstrated in adipocytes that many cis-regulatory elements are
often not conserved between human and murine adipocytes even
though the expression pattern of genes is conserved [28]. They
observed that such motifs were located within linage-specific
transposon insertions. Existence of multiple regulatory elements
around biologically important genes could be a mechanism by
which cells maintain key gene regulations against genomic changes
during evolution. Clustering of regulatory elements could also
result from an accumulative effect of such evolutional genomic
changes.
Computational motif analysis is used to discover new transcrip-
tion-factor binding motifs in sequences inferred from genome-wide
studies such as ChIP-seq [61]. In genome-wide ChIP analysis of
transcription factors, motif analysis is used to obtain their accurate
binding motifs and discover unknown DNA binding factors that co-
localize with the transcription factors of interest, for example, see
[27,62,63]. The analyses, however, relied on prior knowledge
about transcription factors and the regions to be analyzed are
limited to their biding sites. In contrast, the combination of motif
analyses and mapping of regulatory elements by FAIRE-seq does
not require such prior knowledge, hence offers a distinct
advantage in unbiased screening for novel transcription factors
important in given biological processes. In our study, we retrieved
the motifs for PPARc and C/EBPs and for known regulators that
top the list of the motifs identified in the adipocyte- or
preadipocyte-specific FAIRE peaks (Figure 5, Figures S6 and
S7). Furthermore, we demonstrated that NFIA and NFIB were
functionally required for proper adipocyte differentiation
(Figure 6). These results demonstrated that motif analyses of cell
type–specific FAIRE peaks are useful in identifying regulators of a
biological process in an unbiased manner.
To our knowledge, few studies have employed motif analysis
and our unbiased approaches in investigating enhancer-like DNA
regions. Mikkelsen et al. recently employed ChIP-seq for H3K27ac
to define enhancer regions specific for adipocyte differentiation.
Both studies similarly detected the motifs for PPAR, C/EBPs and
Figure 8. NFI occupy the adipocyte-specific FAIRE peaks and/or the PPARc binding sites near PPARc, C/EBPa, and aP2 genes. (A) The
NFI binding motifs identified in the adipocyte-specific FAIRE peaks and/or the PPARc binding sites in the vicinity of PPARc, C/EBPa and aP2. For site
numbers, see (B). (B) Genomic location of the regions examined. B1 and B2 are unrelated genomic regions used as background negative controls. (C)
ChIP-qPCR analysis using an anti-NFI antibody (H-300). (D) Percent fraction of genes harboring NFI motifs in non-promoter FAIRE peaks (within
625 kb) were higher when the genes were bound by PPARc (within 625 kb) and induced during differentiation.
doi:10.1371/journal.pgen.1002311.g008
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Mikkelsen discovered PLZF and SRF as novel negative regulators
[28] and we found NFIA and NFIB as regulators of adipocyte
differentiation—perhaps due to differences in methods. First, we
directly compared FAIRE peaks and H3K27ac peaks detected in
the Mikkelsen study and found considerable, but not complete,
overlap especially in the non-promoter regions: 94% of 10,461
promoter FAIRE peaks and 45% of 27,320 non-promoter FAIRE
peaks overlapped H3K27ac in 3T3-L1 on day 0. There may be
different classes ofenhancerelementsthat prefer eitherH3K27ac or
open chromatin. Also, we used two parameters to sort motifs: the
statistical significance of enrichment (p-value) in either kind of cell
type–specificFAIRE peaks;and the motif enrichment ratio between
the adipocyte- and preadipocyte-specific FAIRE peaks (see [28]).
The combination guarantees significant enrichment of the peaks’
motifs and the difference in their number depending on whether
they are adipocyte- or preadiocyle-specific. The motifs for PLZF
and SRF were not on the top of our list since the p-values were not
significant—probably due to relatively lower occurrence, although
we also found a significant enrichment ratio of 0.37 and 0.50,
respectively. We calculated p-values and the enrichment ratios of
the top motifs in the Mikkelsen’s study by using our adipocyte- and
preadipocyte-specific FAIRE peaks and found general similarity
(Figure S10). Overall, both studies notably demonstrate the utility of
the combining computational motif analysis and unbiased mapping
of regulatory elements in identifying new regulators of adipocyte
differentiation.
Siersbæk et al. recently employed DNase-seq to investigate
genome-wide change in open chromatin structure at various time
points during 3T3-L1 differentiation [6]. They reported dramatic
increase in the number of open chromatin sites in the first hours of
differentiation. Such regions included what they termed ‘‘hot
spots’’ that were bound by multiple adipogenic regulators,
facilitating binding of PPARc and C/EBPa during the late stage
of differentiation. We found that the DNaseI hypersensitive sites in
3T3-L1 cells on day 0 or day 6 in the Siersbaek study [6]
significantly overlapped the FAIRE peaks on day 0 or day 8 in our
study (78.8% and 80.9%, respectively) (Figure S11), suggesting
that both methods detect similar open chromatin regions.
Although limited amount of motif analyses of the DNase I sites
was conducted in their study, we think a combination of motif
analysis and DNase-seq should work in a similar way.
The NFI family was identified as site-specific DNA-binding
protein that bound to the adenovirus origin of replication [56,57].
Although defects in development of organs such as brain, lung,
tooth, bone and skeletal muscle in Nfia, Nifb, Nifc and Nfix-deficient
mice were documented [64,65,66,67,68,69], no publication has
reported direct evidence that NFI family transcription factors are
involved in adipogenesis, but it is a reasonable supposition since
bone, muscle and adipocytes have a common mesenchymal
precursor [70]. Interestingly, Graves et al. demonstrated that NFI
was bound to the adipogenic 25.4 kb enhancer region in the aP2
promoter [71], which is the original adipogenic enhancer region
where the PPARc/RXR heterodimer was found to bind and act
[72]. The NFI binding motif they examined by gel shift assay [72]
was close to the best-characterized PPARc binding sites in the
region, and was also in site 9 (Figure 8A, right panel, site 9), which
was indeed bound by NFI in ChIP assay (Figure 8C). Forced
overexpression of NFIA in 3T3-L1 cells dramatically induced
expression of PPARc, C/EBPa and aP2 and caused lipid droplet
formationbeforeinitiationof differentiation.OurChIP data suggest
that activation of these genes by NFIA is through direct binding of
NFI to regulatory elements near these genes. In overexpression
experiments, NFIB did not activate the adipogenic genes (Figure 7).
NFI factors are known to undergo extensive alternative splicing
[57]. We speculate that this could be due to truncation of the C-
terminus caused by lack of exons 10 and 11 in the NFIB cDNA that
we cloned (NM_001113209.1) while the NFIA clone completely
matched NM_010905.3. NFI was also implicated in functions of
other nuclear receptors such as the androgen receptor (AR),
estrogen receptor (ER) and glucocorticoid receptor [4,73,74].
Further studies are necessary to elucidate the mode of action of
NFIs and positioning of NFIs in the adipogenic regulatory network.
Materials and Methods
Cell Culture
3T3-L1, NIH-3T3, 3T3-F442A and HEK293T cells were
maintained inDMEM,supplemented with10%FBS.Foradipocyte
differentiation, two days after confluence, 3T3-L1 cells were treated
with dexamethasone (1 mM), IBMX (0.5 mM), and insulin (5 mg/
ml) (DMI) for 48 hours, followed by treatment with insulin alone,
with medium replacement every two days thereafter. For dif-
ferentiation of 3T3-F442A, cells were treated with insulin (5 mg/ml)
after confluence, with medium replacement every two days.
Animal Studies
All animal works have been conducted according to the
institutional guidelines.
Antibodies
Generation of characterization of antibodies for human PPARc
and human RXRa was described previously [24]. Rabbit
polyclonal anti-histone H3 trimethyl K4 (ab8580) was from
Abcam. Antibodies against CTCF were from Upstate (#07–
729). Anti-NFI antibody (H-300) was from Santa Cruz (sc-5567).
FAIRE
FAIRE experiments were performed based on a protocol
published by Giresi et al. [7]. Briefly, cells were fixed with 1%
formaldehyde for five minutes at room temperature, the fixation
stopped by adding 2.5 M glycine (final 125 mM). Fixed cells were
scraped and collected in 15 ml tubes (4610‘6 cells/tube) and
washed twice with cold PBS, then 8610
6 cells were re-suspended
in 800 ml of MC lysis buffer (10 mM Tris-HCl pH 7.5, 10 mM
NaCl, 3 mM MgCl2, 0.5% NP-40) and incubated on ice for ten
minutes. After spinning for four minutes at 8000 rpm, the pellet
was re-suspended in 400 ml SDS lysis buffer (1% SDS, 10 mM
EDTA, 50 mM Tris-HCl pH 8.0, proteinase inhibitor cocktail)
and incubated on ice for ten minutes. Glass beads (size, 200 mg)
(Polysciences Inc. #05483-250) were added and the DNA was
sheared by sonicator. Next, we added 200 ml cold ChIP dilution
buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris-HCl pH 8.0, 167 mM NaCl), and after spinning
for one minute at 8,000 rpm, supernatant was transferred to a new
1.5 ml tube. Aliquote was taken, de-crosslinked, purified by
phenol/chloroform extraction, and run on a gel to ensure average
fragment sizes of 300 bp. Remaining samples were processed three
times by phenol/chloroform extraction to recover DNA not bound
by nucleosome in the water phase. The samples were de-
crosslinked by overnight incubation at 65uC and purified by
ethanol precipitation. They were subsequently treated with RNase
A (final 50 ug/ml), purified by QIAquick PCR purification kit
(Qiagen) and used for subsequent analyses.
Chromatin Immunoprecipitation (ChIP)
ChIP was performed as descried previously [24,75]. For ChIP
using anti-PPARc, RXRa and CTCF antibodies, 3T3-L1 cells
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temperature and were prepared for ChIP as described previously.
For ChIP using anti-H3K4me3 antibody, the nuclei of 3T3-L1
cells were prepared by centrifugation through a sucrose gradient
and were digested with MNase (TaKaRa). After centrifugation,
the supernatant was used for ChIP. Sequences of primers used for
qPCR were listed in Table S1.
High-Throughput Sequencing and Peak Detection
High-throughput sequencing was performed by using the
Genome Analyzer System (GA II) (Illumina) as described
elsewhere [76]. In short, we repaired ends of DNA samples,
created 39-dA overhang, ligated Illumina adaptors, size-fractioned
the samples by gel extraction and amplified them with 8 cycles of
PCR according to the manufacturer’s instructions. We then
purified the DNA and performed cluster generation and 36 cycles
of sequencing on an Illumina cluster station and 1G analyzer
following the manufacturer’s instructions. Sequences were mapped
to the reference murine genome, NCBI build 37 (mm9). Peak
detection was performed using Findpeaks 3.1.9.2 [77] with a false
discovery rate (FDR) cut-off of 1610
24. Operations such as
intersections, unions, and subtractions of genome regions were
performed with a web-based GALAXY genome analysis tool
[78,79].
Average Signal Profiling
Average profiling of FAIRE and histone modifications near
transcription start sites or FAIRE peaks were generated using
‘‘sitepro’’ in the CEAS package [80].
Adipocyte- and Preadipocyte-Specific FAIRE Peaks
For definition, we first ranked peaks based on signal intensity,
which were detected in 3T3-L1 on either day 0 or day 8 with a
FDR of 10
24. We then classified each peak into tertiles (high, mid,
low) for either day the peak that had the higher percentile (see also
the 4-by-4 table in Figure 3B).
Gene Ontology Analysis
Gene ontology annotation analysis was performed using
DAVID (ver. 6.7) [38]. The top 2,000 genes were used, sorted
by the number and maximum height of the adipocyte-specific
FAIRE peaks within a region 625 kb from TSS. For genes bound
by PPARc, we used the top 931 genes with more than three
PPARc binding sites within a region 625 kb from TSS. To detect
enrichment of specific—rather than general—terms, following the
instructions of DAVID’s developer, we used GOTERM_BP_4
and GOTERM_BP_5, and sorted result lists by using both fold
enrichment and Benjaini p-value [38,81].
Clustering Analysis
Statistical clustering analyses of the PPARc binding sites and the
adipocyte-specific FAIRE peaks were performed as described in
references [47,48].
Enriched Motif Analysis
Enrichment analyses of known motifs were performed with
AME ver. 4.6.0 in the MEME suite [82]. After removing repeat
regions with RepeatMasker [83], DNA sequences from the center
150 bpregions ofthetop 2,000 celltype–specificFAIREpeakswere
analyzed with a fixing partition of 2,000, dinucleotide randomiza-
tion and p-value threshold of 10
24 and p-value report threshold of
0.05. We used the licensed version of TRANSFAC database
(Release 2010.4) [51] and the JASPAR CORE database [52].
Motif enrichment ratios (adipocyte-/preadipocytes-specific
FAIRE) for motifs in the TRANSFAC or JASPAR CORE
database were determined by a method described in reference
[28]. Instances of motifs were enumerated in the adipocyte- or
preadipocytes-specific FAIRE peaks by using FIMO ver. 4.6.0 in
the MEME suite, with a p-value threshold of 10
24, normalized by
total nucleotide length. Motif enrichment ratios were determined
by dividing the normalized adipocyte enrichment values by
preadipocyte values.
MEME ver. 4.3.0 [40] was used to identify de novo motifs
over-represented in the adipocyte- or preadipocyte-specific
FAIRE peaks and the PPARc binding sites. After removing
repeat regions with RepeatMasker [83], DNA sequences from the
center 150 bp regions of the top 800 cell type–specific FAIRE
peaks with higher signals were used for the analyses. Identified
enriched de novo motifs were next analyzed by TOMTOM in
the MEME suite for comparison against a database of known
motifs.
Gel Shift Assay and Reporter Assay
The Gel shift assay and luciferase reporter assay were performed
as previously described [84,85]. For the luciferase assay, putative
PPRE motifs were cloned in tandem (36or 66) into pGL3 basic
reporter plasmid (Promega) together with the tk minimal promoter.
The 25.4 kb aP2 promoter luciferase construct is described in
reference [84].
Knockdown of NFIA and NFIB by siRNA in 3T3-L1 Cell
Differentiation
The 3T3-L1 cells were transfected with either control siRNA or
siRNA for murine NFIA and NFIB (Santa Cruz Biotechnology, sc-
37007, sc-36045 and sc-43566, Sigma MISSION siRNA,
SASI_Mm02_00309629, 00309630, 00307243, 00307244) by
using Lipofectamine RNAiMAX (Invitrogen) just before they
reached confluence. Induction of differentiation (the DMI
treatment) was started two days after confluence, as described in
a method for differentiation of 3T3-L1 cells.
Oil-Red-O Staining
The 3T3-L1 adipocytes were washed with PBS, fixed with
formalin for 30 minutes at room temperature, rinsed with 60%
isopropanol and stained with oil red O solution—freshly made by
mixing 0.5% oil red O in isopropyl alcohol and water (3:2)—and
left to sit for one hour; the cells were then washed with water and
dried.
mRNA Expression Analysis
Total RNA was isolated using TRIzol reagent (Invitrogen), then
0.5 mg of the total RNA was reverse transcribed using high-
capacity cDNA reverse transcription kits (Applied Biosystems
#4375222) and random hexamers. Real-time quantitative PCR
(SYBR green) analysis was performed on a 7900HT Fast Real-
Time PCR System (Applied Biosystems). Primer sequences are
listed in Table S1. Expression was normalized to 36B4.
Microarray Analysis
Transcriptome analysis of 3T3-L1 during differentiation by
using a GeneChip Mouse Genome 430 2.0 array (Affimetrix) was
described previously [24]. Heat maps were generated by using
GENOMICA, developed by Yaniv Lubling and Eran Segal at the
Weizmann Institute of Science. Microarray data of 3T3-L1 and
NIH-3T3 cells used in Figure S11 was obtained from GEO
(accession number GSE10246).
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We amplified NFIA and NFIB coding sequences from cDNA
prepared from adipocytes using primers listed in Table S1, and
cloned them into retroviral pMXs-puro vectors. We also made a
dominant negative NFIA that lacks the C-terminal transactiva-
tion/repression domain (NFIA-DN) [58]. Plat E cells were
transfected with pMXs-puro plasmids using Lipofectamine 2000
(Invitrogen). Culture medium containing viruses after two day
incubation was centrifuged at 2,000 rpm for 5 min and superna-
tant was collected and supplemented with 10 mg/ml polybrene.
Conditioned medium with viruses was used to infect 3T3-L1 cells
and then selection was started by adding 2 mg/ml puromycin and
incubated for 2 days.
Accession Numbers
FAIRE-seq and ChIP-seq raw data are deposited into the DNA
data bank of Japan (DDBJ accession number: DRA000378).
Supporting Information
Figure S1 Genomic distribution and characterization of pro-
moter and non-promoter FAIRE peaks in 3T3-L1. (A) Location
analysis of FAIRE peaks relative to RefSeq genes in 3T3-L1 (day
0). Promoter FAIRE peaks were defined as those located within +/
2500 bp of RefSeq transcription start sites (TSSs). Notably, only
8% of the non-promoter FAIRE peaks were located in the 25k b
proximal promoter region, and the vast majority of them were
located in distal regions such as introns and intergenic regions. (B)
Average profiles of FAIRE and H3K4me3 signals around the
TSSs of genes with high, moderate and low expression levels.
Signal intensity from microarray data was used for classification by
the signal’s expression levels. The X-axis indicates distance from
the TSS. (C) Percent fractions of the FAIRE peaks (promoter and
non-promoter) that overlapped CTCF binding sites as well as
H3K4me1 and H3K4me3 positive regions. (D) Average profiles of
FAIRE, H3K4me1, H3K4me3, and H3K27ac signals around the
FAIRE peaks in promoter and non-promoter regions. The X-axis
shows distance from the center of the FAIRE peaks. The FAIRE
peaks located within +/2100 bp from RefSeq TSSs were
analyzed for promoter FAIRE peaks. The promoter FAIRE peaks
showed H3K4me3(+)/H3K4me1(2) modification whereas the
non-promoter FAIRE peaks showed H3K4me3(2)/H3K4me1(+)
modification.
(TIF)
Figure S2 Clustering of multiple adipocyte-specific non-pro-
moter FAIRE peaks and PPARc binding sites near Mgll, Adipor2
and Slc2a4. Clusters of multiple adipocyte-specific FAIRE peaks
and/or PPARc binding sites were located in genomic regions near
Mgll (A), Adipor2 (B) and Slc2a4(Glut4) (C) in 3T3-L1 adipocytes.
In some cases—e.g., Slc2ar4 (Glut4) and Ybx2 in (C)—multiple
genes were located in such regions. Bars below the FAIRE
signal represent statistically significant FAIRE positive peaks
(FDR,10
24). Red asterisks indicate the adipocyte-specific FAIRE
peaks on day 8 (see Figure 2B for definition). Blue arrow heads in
(B) indicate the PPARc binding regions in the intron 1 of Adipor2
tested in Figure 3.
(TIF)
Figure S3 Clustering of multiple adipocyte-specific non-pro-
moter FAIRE peaks and PPARc binding sites near Cebpa,
Srebf1and Cidec. Clusters of multiple adipocyte-specific FAIRE
peaks and/or PPARc binding sites were located in genomic
regions near Cebpa (A), Srebf1 (B) and Cidec (C).
(TIF)
Figure S4 Binding sites for PPARc and RXRa in 3T3-L1 cells.
(A) De novo motif analysis (MEME) of the center 150 bp of the
PPARc/RXRa binding regions (top 400) in 3T3-L1, day 8. Of
note, there is a 59 extension AGT, which corresponds to the
interaction between the PPARc hinge region and DNA identified
by crystal structure analysis [41]. (B) A heat map showing
enrichment of PPARc in the vicinity of genes up-regulated during
differentiation. The horizontal bars in the right panel indicate each
gene bound by PPARc (+/225 kb from TSS, day 8) (C) Ontology
analysis with DAVID of genes bound by PPARc [13].
(TIF)
Figure S5 Co-regulation of neighboring genes during adipocyte
differentiation. (A, B) Genomic loci near (A) co-regulated Mrpl12,
Slc25a10 and Gcgr and (B) co-regulated Hsd11b1, G0s2 and Lamb3.
Note, there are clusters of the adipocyte-specific FAIRE peaks
(asterisks) and the PPARc binding sites encompassing the co-
regulated genes. (C) Microarray analysis showing co-regulation of
Mrpl12, Slc25a10 and Gcgr, and co-regulation of Hsd11b1, G0s2
and Lamb3 included in the clusters of multiple adipocyte-specific
FAIRE peak and PPARc binding sites.
(TIF)
Figure S6 Known motif enrichment analysis of the adipocyte- or
preadipocyte-specific FAIRE peaks (JASPAR CORE motifs).
Enrichment analysis of the adipocyte- (left) and the preadipo-
cyte-specific (right) FAIRE peaks for known motifs in the JASPAR
CORE database performed with AME in the MEME suite by the
same methods used in Figure 5.
(TIF)
Figure S7 De novo motif analysis of the adipocyte-specific
FAIRE peaks. MEME ver. 4.3.0 was used to identify de novo
motifs over-represented in the adipocyte- and preadipocyte-
specific FAIRE peaks and PPARc binding sites. After removing
repeat regions, DNA sequences from the center 150 bp regions of
top 800 cell type–specific FAIRE peaks with higher signals were
used for the analyses. Identified enriched de novo motifs were
analyzed by TOMTOM in the MEME suite for comparison
against a database of known motifs.
(TIF)
Figure S8 Suppression of adipocyte differentiation by knock-
down of NFIA and NFIB by using different siRNAs.
(TIF)
Figure S9 Comparison of FAIRE Peaks between undifferenti-
ated 3T3-L1 and NIH-3T3 cells. (A) A heat map showing
enrichment of the 3T3-L1- and NIH-3T3-specific FAIRE peaks in
the vicinity (+/225 kb from TSS) of genes sorted by using the
ratio of expression levels in 3T3-L1 or NIH-3T3. The FAIRE
peaks specific to 3T3-L1 or NIH-3T3 were enriched in the vicinity
of genes whose expression levels were higher in 3T3-L1 or NIH-
3T3, respectively. (B) Known motif analysis of the 3T3-L1-specific
FAIRE peaks (vs NIH-3T3). The binding motif for EBF and
PPARc/RXR were among the top scored motifs.
(TIF)
Figure S10 The enrichment ratios of the top motifs in
Mikkelsen’s study [28] by using the adipocyte- and preadipo-
cyte-specific FAIRE peaks.
(TIF)
Figure S11 Comparison of DNase-seq in Siersbæk’s study [6]
and FAIRE-seq peaks near Klf5, Pparg and Cebpa gene. DHS stands
for DNase I hypersensitive sites.
(TIF)
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